The best drug to fight malaria is facing increased resistance from the parasites it fights. Now there's an alternative in the ...

A new-class of antimalarial medication called KLU156 was just found to be as reliable as exiting treatments, and may be ...

Hundreds of malaria patients participating in a Phase 3 clinical trial in Gabon in West Africa were cured via a single dose ...

Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one ...

A new antimalarial drug developed by Novartis is as effective as existing treatments and could help tackle rising drug ...

Novartis plans to seek quick regulatory approvals from health authorities for the drug, known as GanLum, which would be the ...

Promising results from a new malaria drug offer hope against emerging drug resistance in Africa. In a clinical trial, ...

Switzerland-based Novartis has developed a new anti-malaria drug, GanLum, that showed 97% effectiveness in late-stage trials.

In 2022, the WHO hailed Novartis’ GanLum as the most promising non-artemisinin-based combination. The Swiss drugmaker ...

Novartis has reported successful Phase III results for GanLum, a new non-artemisinin antimalarial designed to combat growing ...

The treatment — which could be the first novel antimalarial in decades — showed the ability in testing to combat drug ...